Kris Ver Donck
Kris Ver Donck joined FOx Biosystems in March 2020 as Chief Commercial Officer coordinating marketing, sales and business development.
Graduated as biochemist at the University of Antwerp he has held several positions at Trinean, Ghent, Belgium, at Digilab & Maia Scientific, Geel, Belgium and at Johnson & Johnson pharmaceutical R&D, Beerse, Belgium; and provides consultancy and management services for technology development and introduction, automation and image analysis to life sciences companies, laboratories and technology providers.
He worked with the LCSB at the university of Luxembourg for venture development of HuMiX, a gut-on-chip technology platform for interaction studies between microbiome and human pathologies. He contributed in study, design and implementation of a fully automated pathogenic virus screening lab and of an image data integration project for neuronal research.
As Head of global sales at Trinean, now part of Unchained Labs, he has coordinated and rebuilt the distribution network and managed specific development projects for microvolume quantification spectroscopy.
As CTO and co-founder of the imaging division of Digilab & Maia Scientific he has lead the development of a fully automated high throughput microscopy and image analysis platform for use in e.g. industrial production of monoclonal cell cultures.
At Johnson & Johnson’s pharmaceutical R&D division Janssen Pharmaceutica he designed and implemented the HTS (high throughput screening) facilities, developed pioneer LIMS (Lab Information Management System) and HCS (microscopy image analysis screening) platforms; and supported a cardio-protection drug from research lab to phase II clinical trials.